Introduction
Brugada syndrome is an genetic disorder characterized by sudden cardiac death and associated with mutations of SCN5A gene, which encodes cardiac sodium channel [1] . Fever can precipitate Brugadalike electrocardiographic (ECG) changes [2] . Syncope and sudden death usually ocur at rest or during periods of bradicardia. TENS is the application of low-level electrical current through special electrodes placed on the skin for analgesia. patient diagnosed with left shoulder adhesive capsulitis and TENS was applied for 20 min a constant frequency of 80 HZ for pain relief (Figure 1) . During therapy the patient experienced syncope. He was treated emergently in physical therapy service and we were unable to obtain an ECG trace in physical therapy service during firs session. ECG recordings of the patient were taken at 1, 5, 10 and 15 minutes during second session. ECG recordings showed bradycardia and dynamic ECG changes between type 2 and type 3 pattern ( Figure  2 ). After ten minutes the patient developed presyncope. His blood pressure was 120/80 mmHg. ECG revealed bradycardia and marked QT prolonongation (QTc 425 ms). TENS treatment was stopped and subsequent sessions have been cancelled (Figure 3 ).
Discussion
Brugada syndrome, an entity described in 1992, is characterized by episodes of ventricular tacyarrhythmias or unexpected sudden cardiac death in patients with a structurally normal heart, and a characteristic ECG consisting of a right bundle-branch block (RBBB) pattern and ST segment elevation in the precordial V 1 through V 3 leads [3] . Ventricular arrhythmias more often occur during rest or sleep when the vagal tone is predominant. Increased vagal tone mediated by acetylcholine decreases the calcium currents, which could lead to arrhythmogenesis via phase 2 reentry [4] . TENS is a non-invasive analgesic techique that is used for pain relief. During TENS low-level electrical currents delivered across the intact surface of the skin via electrodes. According to the "Gate Control Theory" of pain, TENS treatment is thought to activate the body's pain inhibitory system. Closure of this gate helps to block incoming pain transmission from periphery and spinal cord. It also stimulates the release of endogenous opioids. This lowlevel electrical currents affect sodium and potassium channels in conduction system and generation of action potential in muscles, nerves and heart [5] [6] [7] . However, virtually no information is available about the effects of TENS treatment on sodium and calcium channels in Brugada syndrome. TENS treatment leads to an increase in parasympathetic activity, resulting in bradycardia. It is known that local increase in body temperature and release of endogenous endorphins during therapy may cause sleepiness [4] . Increased vagal activity has been associated with the development of cardaic arrhythmias in Brugada syndrome. Fever-induced Brugada syndrome is a well-known entity.
In the presented case, there was no conclusive evidence for VF as a potential cause of syncope. Dynamic ECG changes between type 2 and type 3 pattern with bradycardia during second session, a prolonged QTc interval without hypotension could however be interpreted as supporting evidence for VF.
Polymorphic ventricular tachycardia and ventricular fibrillation are the most common arrhythmias in rare cases, syncope in Brugada syndrome may be due to vasovagaal mechanism [8] . This seems unlikely in our patient as his symptoms were unrelated to postural challenge. The effect of TENS on neuron action potential is well-known, but its effect on cardiac myocytes is uncertain. In our case report we would like to draw atttention to the possibility of cardiac arrhythmia during TENS therapy in patients with Brugada syndrome.
